A New Source of a Key Cancer Drug in Low Supply: Genetically Modified Yeast

An international team of researchers has demonstrated that engineered yeast cells can produce the crucial cancer medication vinblastine synthetically. Some cancer patients’ treatments were interrupted...
http://dlvr.it/SZFzk5

Popular Content

Increasing Your Companys ROI: A Strategic Approach

'Squeezed' light might produce breakthroughs in nano-sized electronics

Search ads could arrive in Apple Maps as early as next year

Leo Villareal launches Cosmic Bloom on Outland.art